We identified 25 pathways that were significantly upregulated in AML samples with high LYPD3 expression (Figure 2D, normal p < 0.05), including the E2F signaling pathway, the p53 signaling pathway, the PI3K_AKT signaling pathway, and so forth. The gene discussed is AKT1; the disease is acute myeloid leukemia.